日批在线视频_内射毛片内射国产夫妻_亚洲三级小视频_在线观看亚洲大片短视频_女性向h片资源在线观看_亚洲最大网

Shanghai Pharma eyes new purchases

Updated: 2011-08-16 07:22

By Joy LI(HK Edition)

  Print Mail Large Medium  Small

Shanghai Pharmaceuticals Holdings Co, China's second-largest drug distributor and third-largest drug maker, said on Monday that it expects to boost its portfolio of innovative drugs through a major acquisition in the next six months to a year.

The company laid out its intentions after reporting its first set of interim results since its Hong Kong initial public offering. It called for more acquisitions to build up its core strength on the back of fierce completion and a complex macro environment.

"The potential target could be a mid-sized drug company in the US or Europe owning patent drugs," said Lu Mingfang, chairman of Shanghai Pharma via a teleconference call.

"We hope to make structural improvements to our product portfolio by raising the proportion of innovative drugs, so as to better weather industry risks in the future," Lu added.

Shanghai Pharma, which made its debut on the Hong Kong stock market on May 20, reported on Monday that its net income for the six months ended June 30 surged 65.7 percent to 1.3 billion yuan. Revenue increased 36 percent to 25.21 billion yuan over a year ago.

Revenue from its drug production business reached 4.21 billion, up 11 percent year-on-year. Its distribution business, the other pillar revenue contributor, surged 46.2 percent to 21.17 billion in the first half of 2011.

Xu Guoxiong, executive director and chairman of the company, described the macro-economic and industry environment in the first half as "intricate and complicated."

Industry headwinds included the 27th drug price cut initiated by the National Development and Reform Commission, the nationwide EDL (essential drug list) tendering and the subsequent fall in EDL drug prices driven by the process, and surging prices of raw materials such as Chinese medicine and chemical drugs, according to Xu.

Surging input costs accounted for 70 percent of the decline in Shanghai Pharma's first-half gross profit margin, according to Lu. The gross profit margin of the drug making business dropped 3.3 percentage points to 45.3 percent, while that of the drug distribution business retreated 0.7 percentage point to 7.4 percent.

"The company's full-year gross profit margin of its drug making business is likely to further decline, given that their drug portfolio will not be upgraded in a short period of time and downside policy factors persist," analyst Ding Dan at Guosen Securities wrote in a research note after the company posted its results.

Chairman Lu believes that the deteriorating gross profit margin is a headache facing the entire industry. He said that policy makers will probably intervene in the market for traditional Chinese herbs in the second half of this year.

Lu reaffirmed that the company is "confident" in achieving its profit forecast pledged at its IPO through market expansion and cost reduction.

The company expects its profit attributable to shareholders this year to be no less than 2.1 billion yuan, according to its IPO prospectus.

joyli@chinadailyhk.com

China Daily

(HK Edition 08/16/2011 page2)

主站蜘蛛池模板: 宅男午夜影院 | 亚洲久草| 理论片午夜 | 91传媒理伦片在线观看 | 欧美亚洲三级 | 久久久高清| 午夜视频网 | 18女人毛片| 色无极影院亚洲 | 国产一区二区三区精品在线观看 | 久久久网站 | 天天操天天草 | 欧美性猛交视频 | 蜜桃在线一区 | 欧美日韩中文字幕视频 | 中文字幕精品久久 | 国产视频在线一区 | 九九国产视频 | 欧美一级片在线免费观看 | 亚洲黄色片在线观看 | 99re免费视频 | 日本中文字幕在线观看视频 | 亚色综合| 激情丁香六月 | 丁香在线| 91精品综合久久久久久五月天 | 我我色综合 | 亚洲麻豆精品 | 欧美一二区视频 | 九一精品国产 | 亚洲美女久久 | 在线观看毛片网站 | 国产精品毛片一区视频播 | 亚洲色图一区二区三区 | www.中文字幕在线观看 | 在线免费一级片 | 一区av在线 | 欧美日韩免费 | 超碰夫妻| 爽妇综合网| 国产日本一区二区 |